Buckingham Strategic Wealth’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $29.9K | Hold |
13,234
| – | – | ﹤0.01% | 757 |
|
|
2024
Q1 | $31.6K | Hold |
13,234
| – | – | ﹤0.01% | 750 |
|
|
2023
Q4 | $22K | Hold |
13,234
| – | – | ﹤0.01% | 718 |
|
|
2023
Q3 | $25.4K | Hold |
13,234
| – | – | ﹤0.01% | 682 |
|
|
2023
Q2 | $19.1K | Hold |
13,234
| – | – | ﹤0.01% | 693 |
|
|
2023
Q1 | $15K | Hold |
13,234
| – | – | ﹤0.01% | 615 |
|
|
2022
Q4 | $15K | Hold |
13,234
| – | – | ﹤0.01% | 617 |
|
|
2022
Q3 | $22K | Hold |
13,234
| – | – | ﹤0.01% | 598 |
|
|
2022
Q2 | $17K | Hold |
13,234
| – | – | ﹤0.01% | 601 |
|
|
2022
Q1 | $21K | Hold |
13,234
| – | – | ﹤0.01% | 594 |
|
|
2021
Q4 | $27K | Buy |
13,234
+2,500
| +23% | +$5.1K | ﹤0.01% | 594 |
|
|
2021
Q3 | $42K | Buy |
+10,734
| New | +$42K | ﹤0.01% | 585 |
|
|
2019
Q2 | – | Sell |
-10,000
| Closed | -$51K | – | 447 |
|
|
2019
Q1 | $51K | Hold |
10,000
| – | – | 0.01% | 414 |
|
|
2018
Q4 | $34K | Hold |
10,000
| – | – | 0.01% | 342 |
|
|
2018
Q3 | $60K | Hold |
10,000
| – | – | 0.01% | 356 |
|
|
2018
Q2 | $64K | Hold |
10,000
| – | – | 0.01% | 353 |
|
|
2018
Q1 | $47K | Hold |
10,000
| – | – | 0.01% | 309 |
|
|
2017
Q4 | $33K | Sell |
10,000
-40,000
| -80% | -$132K | 0.01% | 316 |
|
|
2017
Q3 | $107K | Hold |
50,000
| – | – | 0.03% | 281 |
|
|
2017
Q2 | $123K | Hold |
50,000
| – | – | 0.03% | 289 |
|
|
2017
Q1 | $115K | Buy |
+50,000
| New | +$115K | 0.03% | 251 |
|